Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,903.50    -9.50 (-0.50%)
Bid:
1,904.00
Ask:
1,905.00
Spread: 1.00 (0.053%)
Market Cap: £76.34b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

Glaxosmithkline News

GSK gets EU nod for expanded use of Jemperli in endometrial cancer
20 Jan 2025

GSK gets EU nod for expanded use of Jemperli in endometrial cancer

(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to inc...

EU regulators expand usage of GSK's Jemperli cancer drug
20 Jan 2025

EU regulators expand usage of GSK's Jemperli cancer drug

(Sharecast News) - European regulators have expanded the usage of GSK's Jemperli drug for endometrial cancer, the pharmaceutical firm announced on Mon...

UPDATE: Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale
15 Jan 2025

UPDATE: Pfizer cuts stake in Haleon to 7% in GBP2.5 billion share sale

(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securiti...

Pfizer pares back Haleon stake in £2.5bn sale
15 Jan 2025

Pfizer pares back Haleon stake in £2.5bn sale

(Sharecast News) - Pfizer has further reduced its holding in Haleon, it was confirmed on Wednesday, after the drugs giant offloaded 700m shares in a &...

Pfizer to more than halve Haleon holding in GBP2.57 billion sale
14 Jan 2025

Pfizer to more than halve Haleon holding in GBP2.57 billion sale

(Alliance News) - Pfizer Inc is selling 700 million shares in Haleon PLC, more than halving its remaining stake, according to a statement from JPMorga...

London close: Stocks fall, pound weakens further on rising bond yields
13 Jan 2025

London close: Stocks fall, pound weakens further on rising bond yields

(Sharecast News) - London stocks ended Monday in negative territory, pressured by rising bond yields and diminished expectations for near-term interes...

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion
13 Jan 2025

GSK to buy precision therapeutics firm IDRx for up to USD1.15 billion

(Alliance News) - GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its "growing portfol...

LONDON MARKET OPEN: FTSE 100 down, Reeves fails to lift mood
13 Jan 2025

LONDON MARKET OPEN: FTSE 100 down, Reeves fails to lift mood

(Alliance News) - Stock prices in London opened in the red on Monday, after Friday's US jobs data increased expectations of a pause in rate cuts this ...